Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.900
-0.080 (-4.04%)
At close: Aug 25, 2025, 4:00 PM
1.990
+0.090 (4.74%)
After-hours: Aug 25, 2025, 4:15 PM EDT
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $6.25 million as of August 25, 2025. Its market cap has increased by 267.47% in one year.
Market Cap
6.25M
Enterprise Value
1.31M
1-Year Change
267.47%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $160.50M to $6.25M, a decrease of -96.11%. That is a compound annual growth rate of -30.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 6.50M | 195.45% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.27% |
| Dec 31, 2021 | 38.40M | -74.67% |
| Dec 31, 2020 | 151.60M | 413.90% |
| Dec 31, 2019 | 29.50M | 2.08% |
| Dec 31, 2018 | 28.90M | -68.17% |
| Dec 29, 2017 | 90.80M | 85.69% |
| Dec 30, 2016 | 48.90M | -69.53% |
| Jul 20, 2016 | 160.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |